These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29116030)

  • 1. Management of X-linked adrenoleukodystrophy in Morocco: actual situation.
    Benjelloun FZM; Kriouile Y; Cheillan D; Daoud-Tetouani H; Chabraoui L
    BMC Res Notes; 2017 Nov; 10(1):567. PubMed ID: 29116030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overview of X-linked adrenoleukodystrophy in Morocco: results of the implementation of the program of clinical and biological diagnosis].
    Benjelloun FM; Chabraoui L; Kriouile Y
    Pan Afr Med J; 2017; 28():185. PubMed ID: 29599883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.
    Engelen M; Kemp S; de Visser M; van Geel BM; Wanders RJ; Aubourg P; Poll-The BT
    Orphanet J Rare Dis; 2012 Aug; 7():51. PubMed ID: 22889154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
    Stradomska TJ; Tylki-Szymańska A
    Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [X-linked adrenoleukodystrophy: a report of three cases. The importance of early diagnosis].
    López Úbeda M; de Arriba Muñoz A; Ferrer Lozano M; Labarta Aizpún JI; García Jiménez MC
    Arch Argent Pediatr; 2017 Oct; 115(5):e279-e281. PubMed ID: 28895702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study.
    Tran C; Patel J; Stacy H; Mamak EG; Faghfoury H; Raiman J; Clarke JTR; Blaser S; Mercimek-Mahmutoglu S
    Eur J Paediatr Neurol; 2017 Jul; 21(4):600-609. PubMed ID: 28274546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy].
    Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of X-linked adrenoleukodystrophy].
    Xiong H; Zhang YH; Qin J; Xiao JX; Shi CY; Zhou SM; Wu XR
    Zhonghua Er Ke Za Zhi; 2003 Mar; 41(3):203-7. PubMed ID: 14756960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.
    Mahmood A; Dubey P; Moser HW; Moser A
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():55-62. PubMed ID: 16305618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.
    Kemp S; Pujol A; Waterham HR; van Geel BM; Boehm CD; Raymond GV; Cutting GR; Wanders RJ; Moser HW
    Hum Mutat; 2001 Dec; 18(6):499-515. PubMed ID: 11748843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked adrenoleukodystrophy. The Saudi experience.
    Al-Essa MA; Sakati NA; Bakheet SM; Patay ZJ; Dabbagh O; Chaves-Carbello E; Ozand PT
    Saudi Med J; 2000 Jan; 21(1):61-71. PubMed ID: 11533753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES.
    Furlan FLS; Lemes MA; Suguimatsu LCF; Pires CTF; Santos MLSF
    Rev Paul Pediatr; 2019; 37(4):465-471. PubMed ID: 31241695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.
    Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S
    Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked adrenoleukodystrophy.
    Moser HW; Mahmood A; Raymond GV
    Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Japanese patients with X-linked adrenoleukodystrophy and concerns of their families from the 1st registry system.
    Sakurai K; Ohashi T; Shimozawa N; Joo-Hyun S; Okuyama T; Ida H
    Brain Dev; 2019 Jan; 41(1):50-56. PubMed ID: 30077509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in X-linked adrenoleukodystrophy.
    Moser H; Dubey P; Fatemi A
    Curr Opin Neurol; 2004 Jun; 17(3):263-9. PubMed ID: 15167059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines.
    Vogel BH; Bradley SE; Adams DJ; D'Aco K; Erbe RW; Fong C; Iglesias A; Kronn D; Levy P; Morrissey M; Orsini J; Parton P; Pellegrino J; Saavedra-Matiz CA; Shur N; Wasserstein M; Raymond GV; Caggana M
    Mol Genet Metab; 2015 Apr; 114(4):599-603. PubMed ID: 25724074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.